SS Innovations Completes Historic Intercontinental Robotic Cardiac Telesurgery with SSi Mantra 3 System

SS Innovations has completed the world's first intercontinental robotic cardiac telesurgery using its SSi Mantra 3 surgical robotic system. The procedure was performed by Dr. Sudhir Srivastava remotely from IRCAD in Strasbourg, France to the operating room at SAIMS in Indore, India, a distance of over 4,000 miles. The team successfully completed the surgery without any technical issues, demonstrating the capabilities of the SSi Mantra 3 and its revolutionary telesurgery architecture.

SS Innovations International, Inc. (SSII) has achieved a significant milestone in the field of robotic surgery with the successful completion of the world's first intercontinental robotic cardiac telesurgery. The procedure was conducted by Dr. Sudhir Srivastava, utilizing the company's SSi Mantra 3 surgical robotic system. The surgery was remotely performed from the Institute of Research Against Digestive Cancer (IRCAD) in Strasbourg, France, to the operating room at the Sri Aurobindo Institute of Medical Sciences (SAIMS) in Indore, India, a distance of over 4,000 miles.

The procedure, a robotic atrial septal defect closure, was seamlessly executed with the support of a team of specialists, including Dr. Lalit Malik, Dr. Ram Krishna Shukla, and Dr. Bipin Arya, who provided patient-side support in Indore. The live telesurgery was moderated by Dr. Husam H. Balkhy, President of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). The surgery was completed without any technical issues, showcasing the robustness of the SSi Mantra 3 system and its revolutionary telesurgery architecture.

Dr. Srivastava expressed gratitude to Dr. Vipul Patel, Chairman of the Society of Robotic Surgery, and the SS Innovations team for making this historic achievement possible. This landmark event not only demonstrates the advanced capabilities of the SSi Mantra 3 but also paves the way for redefining and democratizing global delivery of complex cardiac care, particularly in regions with limited access to surgical expertise.

The SSi Mantra surgical robotic technology platform, with its telesurgery capabilities, addresses traditional obstacles related to travel, time, cost, and surgical accessibility, creating a more efficient and equitable medical standard. To date, 35 telesurgeries, including 10 cardiac procedures, and a total of 250 cardiac procedures have been successfully completed using the SSi Mantra system. The company is the only surgical robotic company to have received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) for both teleproctoring and telesurgery [1].

The global robotic-assisted surgery systems market is experiencing rapid growth, with a projected size of USD 9.8 billion in 2025, expected to reach USD 21.7 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032. The market is driven by technological advancements, including AI, machine learning, and enhanced imaging modalities, as well as growing demand for minimally invasive procedures and escalating healthcare expenditure [2].

References:
[1] https://www.globenewswire.com/news-release/2025/07/22/3119456/0/en/SS-Innovations-Announces-Completion-of-World-s-First-Intercontinental-Robotic-Cardiac-Telesurgery.html
[2] https://www.openpr.com/news/4112668/robotic-assisted-surgery-systems-market-booming-with